Shares of Johnson & Johnson (JNJ) are higher after Bloomberg reported that the health care products giant was sued by a high school teacher in Australia over an implanted hip-replacement device that stopped selling there due to defects.
J&J allegedly broke Australia's trade law when it sold the device and, therefore, was negligent, the report said, quoting the lawsuit.
J&J shares are up 1.34%, or $0.80, to $60.45.
